Cargando…
Estrogen Related Receptor Alpha (ERRα) a Bridge between Metabolism and Adrenocortical Cancer Progression
SIMPLE SUMMARY: Adrenocortical carcinoma (ACC) is a rare and highly aggressive tumor associated with a very poor prognosis, mostly due to a high risk of recurrence and limited therapeutic options. The identification of “master regulators” of the metabolic changes occurring in cancer cells could offe...
Autores principales: | Avena, Paola, De Luca, Arianna, Chimento, Adele, Nocito, Marta Claudia, Sculco, Sara, La Padula, Davide, Zavaglia, Lucia, Giulietti, Matteo, Hantel, Constanze, Sirianni, Rosa, Casaburi, Ivan, Pezzi, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406166/ https://www.ncbi.nlm.nih.gov/pubmed/36010877 http://dx.doi.org/10.3390/cancers14163885 |
Ejemplares similares
-
SIRT1 is involved in adrenocortical cancer growth and motility
por: Chimento, Adele, et al.
Publicado: (2021) -
Adrenocortical Carcinoma (ACC) Cells Rewire Their Metabolism to Overcome Curcumin Antitumoral Effects Opening a Window of Opportunity to Improve Treatment
por: Nocito, Marta Claudia, et al.
Publicado: (2023) -
Cholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment
por: Casaburi, Ivan, et al.
Publicado: (2018) -
Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC)
por: Casaburi, Ivan, et al.
Publicado: (2015) -
Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability
por: Nocito, Marta Claudia, et al.
Publicado: (2021)